南美和中美疫苗佐剂市场预测至 2030 年 – 区域分析 – 按佐剂类别（矿物盐佐剂、乳液佐剂、脂质体佐剂等）和类型（人用疫苗佐剂和兽用疫苗佐剂）
生物技术和免疫学的进步推动南美和中美疫苗佐剂市场发展
由于对增强疫苗效力的需求不断增长以及疫苗应用范围扩大到传统传染病之外，疫苗佐剂市场带来了重大机遇。随着新病原体的出现和现有病原体的发展，对能够增强免疫反应并提供更广泛保护的佐剂的需求日益增加。生物技术和免疫学的进步正在推动佐剂配方的创新，为预防和治疗疫苗提供新的解决方案。此外，全球疫苗接种计划的增加和疫苗研究资金的增加也推动了市场增长。专注于开发安全性更高、效力更高的佐剂的公司将有能力利用这一不断扩大的市场。与研究机构和生物技术公司建立战略伙伴关系和合作可以进一步增加这一充满活力的领域的机会，使其成为一个有前途的投资和发展领域。
南美和中美疫苗佐剂市场概览
南美和中美疫苗佐剂市场已细分为巴西、阿根廷和南美和中美其他地区。根据公共科学图书馆 (PLOS) 的报告，在疫苗中使用佐剂是提高巴西人口免疫力的关键策略。制造佐剂疫苗被认为是应对流行病等公共卫生紧急情况的准备。因此，巴西政府支持生产佐剂疫苗。例如，巴西制造的“油包水乳剂”已揭示出有效且安全的佐剂疫苗，可诱导对流感抗原的免疫反应。巴西的流感佐剂疫苗生产由圣保罗州立公立机构布坦坦研究所负责，其工业基础设施能够生产季节性和大流行性流感佐剂疫苗。
南美和中美疫苗佐剂市场收入及预测至 2030 年（百万美元）
南美和中美疫苗佐剂市场细分
南美和中美疫苗佐剂市场分为佐剂类别、类型和国家。
根据佐剂类别，南美和中美疫苗佐剂市场分为矿物盐佐剂、乳剂佐剂、脂质体佐剂等。 2022 年，矿物盐佐剂部分在南美和中美疫苗佐剂市场中占有最大份额。
按类型划分，南美和中美疫苗佐剂市场分为人用疫苗佐剂和兽用疫苗佐剂。2022 年，人用疫苗佐剂部分在南美和中美疫苗佐剂市场中占有较大份额。
按国家划分，南美和中美疫苗佐剂市场分为巴西、阿根廷和南美和中美其他地区。2022 年，巴西占据了南美和中美疫苗佐剂市场的主导地位。
Croda International Plc；CSL Ltd；GSK Plc；Novavax Inc；和 Phibro Animal Health Corp 是南美和中美疫苗佐剂市场的一些领先公司。
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Vaccine Adjuvants Market – Key Market Dynamics
4.1 South & Central America Vaccine Adjuvants Market – Key Market Dynamics
4.2 Market Drivers
4.2.1 Rising Number of Infectious Disease Outbreaks and Pandemic
4.2.2 Approvals of Veterinary Vaccine Adjuvants
4.3 Market Restraints
4.3.1 Product Recalls and Adverse Effects
4.4 Market Opportunity
4.4.1 Advancements in Biotechnology and Immunology
4.5 Future Trends
4.5.1 Technological Advancements
4.6 Impact of Drivers and Restraints:
5. Vaccine Adjuvants Market –South & Central America Market Analysis
5.1 South & Central America Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
5.2 South & Central America Vaccine Adjuvants Market Forecast and Analysis
6. South & Central America Vaccine Adjuvants Market Analysis – by Adjuvant Class
6.1 Overview
6.2 Mineral Salt Adjuvant
6.2.1 Overview
6.2.2 Mineral Salt Adjuvant: South & Central America Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
6.3 Emulsion Adjuvant
6.3.1 Overview
6.3.2 Emulsion Adjuvant: South & Central America Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Liposome Adjuvant
6.4.1 Overview
6.4.2 Liposome Adjuvant: South & Central America Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
6.5 Others
6.5.1 Overview
6.5.2 Others: South & Central America Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
7. South & Central America Vaccine Adjuvants Market Analysis – by Type
7.1 Human Vaccine Adjuvant
7.1.1 Overview
7.1.2 Human Vaccine Adjuvant: South & Central America Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
7.2 Veterinary Vaccine Adjuvant
7.2.1 Overview
7.2.2 Veterinary Vaccine Adjuvant: South & Central America Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
8. South and Central America Vaccine Adjuvants Market –Country Analysis
8.1 South & Central America
8.1.1 South and Central America Vaccine Adjuvants Market – Revenue and Forecast Analysis – by Country
8.1.1.1 Brazil: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.1.1 Overview
8.1.1.1.2 Brazil: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.1.3 Brazil: Vaccine Adjuvants Market Breakdown, by Adjuvant Class
8.1.1.1.4 Brazil: Vaccine Adjuvants Market Breakdown by Type
8.1.1.2 Argentina: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.2.1 Overview
8.1.1.2.2 Argentina: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.2.3 Argentina: Vaccine Adjuvants Market Breakdown, by Adjuvant Class
8.1.1.2.4 Argentina: Vaccine Adjuvants Market Breakdown, by Type
8.1.1.3 Rest of South and Central America Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.3.1 Overview
8.1.1.3.2 Rest of South and Central America Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.3.3 Rest of South and Central America Vaccine Adjuvants Market Breakdown, by Adjuvant Class
8.1.1.3.4 Rest of South and Central America Vaccine Adjuvants Market Breakdown, by Type
9. Industry Landscape
9.1 Overview
9.2 Growth Strategies in the Vaccine Adjuvants Market
9.3 Organic Developments
9.3.1 Overview
9.4 Inorganic Developments
9.4.1 Overview
10. Company Profiles
10.1 GSK Plc
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 CSL Ltd
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Croda International Plc
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Novavax Inc
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Phibro Animal Health Corp
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
11. Appendix
11.1 About The Insight Partners
List of Tables
Table 1. South & Central America Vaccine Adjuvants Market Segmentation
Table 2. South & Central America Vaccine Adjuvants Market Revenue and Forecasts To 2030 (US$ Million)
Table 3. Brazil: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class
Table 4. Brazil: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 5. Argentina: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class
Table 6. Argentina: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 7. Rest of South and Central America Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class
Table 8. Rest of South and Central America Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 9. Organic Developments Done by Companies
Table 10. Inorganic Developments Done by Companies
List of Figures
Figure 1. South & Central America Vaccine Adjuvants Market Segmentation, by Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. South & Central America Vaccine Adjuvants Market Revenue (US$ Million), 2022–2030
Figure 4. South & Central America Vaccine Adjuvants Market Share (%) – by Adjuvant Class (2022 and 2030)
Figure 5. Mineral Salt Adjuvant: South & Central America Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 6. Emulsion Adjuvant: South & Central America Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Liposome Adjuvant: South & Central America Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Others: South & Central America Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. South & Central America Vaccine Adjuvants Market Share (%) – by Type (2022 and 2030)
Figure 10. Human Vaccine Adjuvant: South & Central America Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Veterinary Vaccine Adjuvant: South & Central America Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. South and Central America Vaccine Adjuvants Market by Key Countries – Revenue 2022 (US$ Million)
Figure 13. South and Central America Vaccine Adjuvants Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 14. Brazil: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)
Figure 15. Argentina: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)
Figure 16. Rest of South and Central America Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)
Figure 17. Growth Strategies in the Vaccine Adjuvants Market
- Croda International Plc
- CSL Ltd
- GSK Plc
- Novavax Inc
- Phibro Animal Health Corp
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America vaccine adjuvants market.
- Highlights key business priorities to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the South & Central America vaccine adjuvants market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America vaccine adjuvants market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.